Researchers have discovered an experimental medication that significantly reduces a cholesterol-like particle that can ...

Low low-density lipoprotein cholesterol (LDL-C) levels are associated with a reduced risk for dementia, including Alzheimer ...

People with low levels of low-density lipoprotein cholesterol (LDL-C) in their blood have a lower risk of dementia, a new ...

New Study Says You Might Not Need To. Lower levels of "bad" cholesterol are linked to a new statin combination therapy. There ...

Lower levels of "bad" LDL cholesterol could mean a lower risk of dementia and Alzheimer's disease, a new study says.

Low-density lipoprotein cholesterol (LDL-C) levels below 70 mg/dL were associated with a 26% lower risk of all-cause dementia ...

Verve Therapeutics (NASDAQ:VERV) stock gains as the company wins the FDA fast track designation for VERVE-102, a cholesterol ...

Statin use further reduces dementia risk in individuals with low LDL-C levels, with benefits diminishing at extremely low LDL ...

Now, a study has found that low levels of LDL-C, or ‘bad’ cholesterol, may reduce the risk of developing dementia. Statins, a ...

In addition, in the second half of 2025, Verve remains on track to report the final data for the dose escalation portion of the Heart-2 clinical trial, deliver the opt-in package for the PCSK9 program ...

Verve Therapeutics (VERV) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation for VERVE-102 for the ...